Affiliations 

  • 1 Division of Pharmacy, School of Medicine, University of Tasmania, Australia
  • 2 Faculty of Health Science, Univeristi Sultan Zainal Abidin, Terengganu, Malaysia
  • 3 Department of Pharmaceutical Sciences, Università degli Studi di Milano, Milan, Italy
  • 4 School of Pharmacy, Massachusetts College of Pharmacy and Health Sciences, Boston, USA
  • 5 College of Pharmacy, Qatar University, Doha, Qatar
Ther Adv Drug Saf, 2019;10:2042098619852552.
PMID: 31258886 DOI: 10.1177/2042098619852552

Abstract

Background: The burden of adverse drug event (ADE)-related emergency department (ED) visits is increasing despite several preventive measures. The objective of this paper was to develop and validate a conceptual model for a better understanding of ADE-related ED visits and to guide the design and implementation of effective interventions.

Methods: The development of the model involved a systematic review of the literature using PubMed and Embase databases. Studies reporting the risk factors associated with ADE-related ED visits were included. The methodological qualities of the included studies were assessed using the Mixed Methods Appraisal Tool (MMAT). The model was mapped and validated using face and content validity by an expert panel. Deficiencies and targeted interventions were identified, and steps for the design and implementation were recommended.

Results: The literature search generated 1361 articles, of which 38 were included in the review; 41 risk factors associated with ADE-related ED visits were identified. All factors were mapped, and the model was validated through face and content validity. The model consisted of six concepts related to sociodemographic factors, clinical factors, ADE-related to ED visits, ADE while in the ED, outcomes, and consequences. Interventions could be targeted at the factors identified in each concept to prevent ADE-related ED burden.

Conclusion: A conceptual model to guide the successful design and implementation of strategies to prevent ADE-related ED visits and the occurrence of ADE at ED was developed. Clinicians should take these factors into consideration to prevent untoward events, especially when treating high-risk patients.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.